Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
Clinical trial NCT04297995 · UNKNOWN
Trial details
- NCT number
- NCT04297995
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2024-05-30
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.